1 / 15

Phe

Hyperphenylalaninaemias (HPA) Patomechanism, types. BH 4 -dependent HPA (atypical/malignant PKU) Usually mild PKU/HPA Early CNS symptoms. Fe O 2. GTP. BH 4. BH 2. Tyr. Phe. Phenylketons FeCl 3. DOPA→DA→NA→A →→→ melanin. Norm <120 μ mol/l. PAH.

hetal
Télécharger la présentation

Phe

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hyperphenylalaninaemias (HPA) Patomechanism, types BH4-dependent HPA (atypical/malignant PKU) • Usually mild PKU/HPA • Early CNS symptoms Fe O2 GTP BH4 BH2 Tyr Phe Phenylketons FeCl3 DOPA→DA→NA→A →→→ melanin Norm <120 μmol/l PAH

  2. Incidence of hyperphenilalaninamias

  3. 0. day, screening • MS/MS (aminoacid & acylcarnitine) • Sampling on 3rd day of life • Primary parameter: blood Phe >102 μmol/l(norm < 120) Secondary parameter: Phe/Tyr > 1.5 • Clinical circumstances! • Transient hyperphenylalaninaemia • prematurity (Orn, C3 ↑) • parenteral nutrition (Val, Leu, Thr ↑ • hepatic disease (sepsis, galactosaemia,…) • drugs

  4. Further work-up for suspected HPA newborns Positive result „normal” newborn Blood Phe 102-360 μmol/l Blood Phe >360 μmol/l Repeat screening Clinical examination week 1-3 Phe norm Phe ↑

  5. Clinical work-up for the suspected PKU newbornsAim: definitve diagnosis, HPA typing, starting treatment • Call in the patient – no diet! • Detalied clinical history, family anamnesis • Physical examination • Usually few or no symptoms • Mild Phe elevation + feeding difficulty, hypotonia, myoclonus, seizure, salivation → atypical PKU? • Laboratory studies • Blood Phe, Phe/Tyr (MS/MS) • urine FeCl3, GC-MS • BH4 test • DNA extraction for mutation analysis • EEG

  6. Hyperhenylalaninemia differential diagnoses BH4 test POSITIVE BH4 responsive NEGATIVE BH4 non-responsive Classic PKU / Mild HPA BH4-responsive PKU BH4-dependent (atypical) PKU

  7. BH4 loading Phe > 360 μM normal diet diet BH4 20 mg/kg 0 4 8 12 16 24 blood Phe, Phe/Tyr (MS/MS) POSITIVE (Phe ↓ >30%) → BH4-responsive/atypical PKU? measure pterins, DHPR

  8. Combined Phe + BH4 loading Phe < 360 μM normal diet diet Phe 100 mg/kg Phe 100 mg/kg BH4 20 mg/kg -3 0 4 8 12 16 0 4 8 12 16 24 24 -3 blood Phe, Phe/Tyr (MS/MS) POSITIVE (Phe ↓ >30%) → BH4-responsive/atypical PKU? measure pterins, DHPR

  9. Interpreting the BH4 test result - Case 2 BH4 (20 mg/kg) Phe (100 mg/kg) 888 812 705 Phe (100 mg/kg) 122 45 40 39 1400 1200 1000 800 600 400 200 0 1193 888 Blood Phe (umol/l) BH4-dependent 387 Day 1: -3 0 4 8 12 24 hours Day 2: 24 27 31 35 39 51

  10. Interpreting the BH4 test result - Case 2 670 533 BH4 (20 mg/kg) 440 Phe (100 mg/kg) 254 137 96 65 42 35 1400 1200 1000 800 600 400 200 0 BH4-responsive Blood Phe (umol/l) 412 140 96 Day 1: -3 0 4 8 12 24 hours Day 2: 24 27 31 35 39 51

  11. Molecular genetical diagnoses • Send DNA sample for mutation analysis to Semmelweis University, 2nd Dept. Pediatrics • Screen for 6 most frequent PAH mutation (R408W, R158Q, R261Q, R252W, IVS 10nt546, IVS12 splice-site) • Whole gene sequencing

  12. Classic PKU treament, advices • Treat immediately after diagnosis • Gold standard: Phe-free medical food (enriched with vitamins, trace elements, additional energy) • Breastfeeding is encouraged, ⅓ of daily protein intakeDiet overshoot: Phe-deficiency: lethargy, feeding problem, diarrhea, anaemia, anorexia • In PKU: target Phe-level: 120-360μmol/l • In HPA (120-360 μmol/l): no treament is necessary (except pregnancy)

  13. BH4-deficiency treament, advices • BH4 5-10 mg/kg/day • Neurotransmitter precursors: L-DOPA (Madopar 1-3, 4-7, 8-12 mg/kg/day) 5-hidroxi triptophan (Tript-OH 6-9 mg/kg/day) MAO-B blocker selegiline (0.25 mg/kg/day) • Low-Phe diet if necessary

  14. Follow-up • Blood sample via mail regularly • Control check-ups: 0-3 years: every 3 months 3-6 years: every 6 months > 6 years: yearlyPhysical examination, laboratory studies

  15. Patient education

More Related